Company intelligence / Profile preview

Bon Opus Biosciences

Millburn, New Jersey, United Statesbonopusbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bon Opus Biosciences is an active supplier of high-quality recombinant proteins, antibodies, peptides, and gene synthesis services for the life sciences research community. They do not have clinical programs or results as they are not developing therapeutics but supporting academic and industrial R&D with essential reagents.

Modalities: Recombinant proteinPeptidesAntibodyEnzyme
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Bon Opus Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bon Opus Biosciences.

Explore the full profile